Exploring redox imbalance and inflammation for asthma therapy
- 30 July 2023
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (9) , 7851-7865
Abstract
Background:Asthma is a prolonged inflammatory disorder of the airways, that affects an estimated 300 million people worldwide. Asthma is triggered by numerous endogenous and exogenous stimuli with symptoms like wheezing, cough, short of breath, chest tightening, airway obstruction, and hyperreactivity observed in patients. Objective: The review seeks to identify targets of redox imbalance and inflammation that could be explored to create effective treatments for asthma. Methods: The methodology involved a search and review of literature relating to asthma pathogenesis, redox homeostasis, and inflammation. Results: Eosinophils and neutrophils are involved in asthma pathogenesis. These inflammatory cells generate high levels of endogenous oxidants such as hydrogen peroxide and superoxide, which could result in redox imbalance in the airways of asthmatics. Redox imbalance occurs when the antioxidant systems becomes overwhelmed resulting in oxidative stress. Oxidative stress and inflammation have been linked with asthma inflammation and severity. Reactive oxygen species (ROS)/reactive nitrogen species (RNS) cause lung inflammation by activating nuclear factor kappa-B (NF-κB), mitogen-activated protein kinase (MAPK), activator protein-1, as well as additional transcription factors. These factors stimulate cytokine production which ultimately activates inflammatory cells in the bronchi, causing lung cellular injury and destruction. ROS/RNS is also produced by these inflammatory cells to eradicate invading bacteria. Antioxidant treatments for asthma have not yet been fully explored. Conclusion: Redox and inflammatory processes are viable targets that could be explored to create better therapy for asthma.Keywords
This publication has 105 references indexed in Scilit:
- Sustained Elevation of Systemic Oxidative Stress and Inflammation in Exacerbation and Remission of AsthmaISRN Allergy, 2013
- S-Nitrosoglutathione Reductase Inhibition Regulates Allergen-Induced Lung Inflammation and Airway HyperreactivityPLOS ONE, 2013
- Resolution of inflammation: an integrated viewEMBO Molecular Medicine, 2013
- Persistence of effectiveness of bronchial thermoplasty in patients with severe asthmaAnnals of Allergy, Asthma & Immunology, 2011
- Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research ProgramJournal of Allergy and Clinical Immunology, 2011
- Oxidative Stress in AsthmaWorld Allergy Organization Journal, 2011
- Predicting Intermediate Phenotypes in Asthma Using Bronchoalveolar Lavage‐Derived CytokinesClinical and Translational Science, 2010
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Redox Control of Asthma: Molecular Mechanisms and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2010
- Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthmaClinical & Experimental Allergy, 2004